4.5 Article

Donor scoring system for heart transplantation and the impact on patient survival

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 31, Issue 4, Pages 387-397

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2011.11.005

Keywords

extended criteria donor hearts; heart donor quality score; heart transplantation; donor risk assessment; heart allocation

Ask authors/readers for more resources

BACKGROUND: The aim of this study was to design and validate a heart donor score that reflects experts' perceived risk of allograft failure. METHODS: All heart donors reported to Eurotransplant between January 1, 2005 and December 31, 2008 (N = 4,110) were used to create a donor score. Based on observed discard rates and using multivariate regression, points were assigned for the following donor factors: age; cause of death; body mass index (BMI); diabetes mellitus (DM); duration of ICU stay; compromised history (drug, abuse, sepsis, meningitis, malignancy, HBsAg(+) or anti-HCV+); hypertension; cardiac arrest; echocardiography; coronary angiogram; serum sodium; and noradrenaline and dopamine/dobutamine doses. The donor score was obtained by adding all points. All heart donors reported to Eurotransplant in 2009 were included to validate the score (N = 885). RESULTS: All donor factors, except BMI, DM and duration of ICU stay, significantly predicted discard. Based on the median value of the score, donors were classified into low-risk donors (LRDs: <= 16 points) and high-risk donors (HRDs: >= 17 points). In the validation set, discard rates were significantly different when comparing HRDs (35%) and LRDs (7%) (p < 0.0001). In addition, the heart donor score was significantly associated with 3-year survival: LRD 81.5% vs HRD 70.0% (p = 0.004). CONCLUSIONS: The heart donor score accurately reflects the likelihood of organ acceptance and predicts long-term patient mortality. Application of this score at time of donor reporting may facilitate donor risk assessment and allow for more appropriate matching of extended criteria donor hearts. J Heart Lung Transplant 2012;31:387-97 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Impact of Less Invasive Left Ventricular Assist Device Implantation on Heart Transplant Outcomes

Julia Riebandt, Dominik Wiedemann, Sigrid Sandner, Philipp Angleitner, Andreas Zuckermann, Thomas Schloeglhofer, Guenther Laufer, Daniel Zimpfer

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Engineering, Biomedical

The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension

P. H. I. L. I. P. P. ANGLEITNER, T. H. O. M. A. S. SCHLOEGLHOFER, D. O. M. I. N. I. K. WIEDEMANN, J. U. L. I. A. RIEBANDT, A. N. D. R. E. A. S. STRASSL, J. U. L. I. A. MASCHERBAUER, M. A. T. T. H. I. A. S. KAINZ, G. U. E. N. T. H. E. R. LAUFER, A. N. D. R. E. A. S. ZUCKERMANN, D. A. N. I. E. L. ZIMPFER

Summary: In this case report, we present a patient with apical hypertrophic cardiomyopathy and severe fixed pulmonary hypertension. To make the patient eligible for heart transplantation, continuous left-ventricular unloading with a left-ventricular assist device was performed, and the reversal of pulmonary hypertension was assessed using a cardiac pressure sensor.

ASAIO JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes

Philip F. Halloran, Katelynn Madill-Thomsen, Arezu Z. Aliabadi-Zuckermann, Martin Cadeiras, Marisa G. Crespo-Leiro, Eugene C. Depasquale, Mario Deng, Johannes Gokler, Daniel H. Kim, Jon Kobashigawa, Peter Macdonald, Luciano Potena, Keyur Shah, Josef Stehlik, Andreas Zuckermann

Summary: This study extended the MMDx system to classify heart transplant endomyocardial biopsies into a new Minor category characterized by low-level inflammation and ABMR-related gene expression. The results suggest that low-level ABMR-related molecular stress may be operating in more hearts than previously estimated.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Anesthesiology

Perioperative Risk Factors for Intensive Care Unit Readmissions and Mortality After Cardiac Surgery

Caroline Holaubek, Fabian Winter, Anita Lesjak, Arezu Aliabadi-Zuckermann, Philipp Opfermann, Bernhard Urbanek, Christine Schloemmer, Mohamed Mouhieddine, Andreas Zuckermann, Barbara Steinlechner

Summary: The study aimed to identify perioperative risk factors for intensive care unit readmission and in-hospital death after cardiac surgery. Preoperative risk factors such as end-stage renal failure, arrhythmia, chronic obstructive pulmonary disease, age over 80, and high European System for Cardiac Operative Risk Evaluation II score were associated with ICU readmission. Readmitted patients had a higher mortality rate compared to nonreadmitted patients.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)

Review Cardiac & Cardiovascular Systems

Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies

Maria Generosa Crespo-Leiro, Maria Rosa Costanzo, Finn Gustafsson, Kiran K. Khush, Peter S. Macdonald, Luciano Potena, Josef Stehlik, Andreas Zuckermann, Mandeep R. Mehra

Summary: Heart transplantation faces challenges including limited organ pool, personalized immunosuppressive therapy, and minimizing late complications. Advances such as using hepatitis C-infected donors, expanding donor source, and new preservation techniques have increased organ availability. Mechanical circulatory support has helped patients with advanced heart failure maintain organ function while waiting for a suitable donor match.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD)

Are Martin Holm, Andrew Courtwright, Anne Olland, Andreas Zuckermann, Dirk Van Raemdonck

Summary: This document outlines the International Society for Heart and Lung Transplantation's position on thoracic organ transplantation using Controlled organ donation after circulatory determination of death, and includes a position on methods to ensure the viability of organs after certification of death.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Medicine, General & Internal

A Prospective Observational Study on Multiplate(R)-, ROTEM(R)- and Thrombin Generation Examinations Before and Early After Implantation of a Left Ventricular Assist Device (LVAD)

Philipp Opfermann, Alessia Felli, Christine Schloemmer, Martin Dworschak, Michele Bevilacqua, Mohamed Mouhieddine, Daniel Zimpfer, Andreas Zuckermann, Barbara Steinlechner

Summary: This study found that preoperative Multiplate(R) and ROTEM(R) measurements can serve as indicators for assessing the risk of postoperative bleeding in LVAD patients, providing guidance for perioperative clinical management.

FRONTIERS IN MEDICINE (2022)

Article Biology

EGR1 Is Implicated in Right Ventricular Cardiac Remodeling Associated with Pulmonary Hypertension

Maria Laggner, Felicitas Oberndorfer, Bahar Golabi, Jonas Bauer, Andreas Zuckermann, Philipp Hacker, Irene Lang, Nika Skoro-Sajer, Christian Gerges, Shahrokh Taghavi, Peter Jaksch, Michael Mildner, Hendrik Jan Ankersmit, Bernhard Moser

Summary: This study investigated the gene expression profiles of hypertrophic and regenerated right hearts of two subtypes of pulmonary hypertension (PH) patients. The findings revealed unique gene alteration signatures in different PH subtypes, as well as the identification of a profibrotic factor, early growth response 1 (EGR1), in both subtypes. These findings may contribute to the identification of therapeutic candidates for PH patients who are not eligible for surgical treatment.

BIOLOGY-BASEL (2022)

Review Biology

Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis

Markus J. Barten, Fausto Baldanti, Alexander Staus, Christian M. Hueber, Kyriaki Glynou, Andreas Zuckermann

Summary: This meta-analysis suggests that prophylactic CMVIG treatment in solid organ transplantation patients can reduce the risk of CMV infection. This is particularly beneficial for patients at high risk of CMV infection or disease.

LIFE-BASEL (2022)

Article Cardiac & Cardiovascular Systems

ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery

Dana P. McGlothlin, John Granton, Walter Klepetko, Maurice Beghetti, Erika B. Rosenzweig, Paul A. Corris, Evelyn Horn, Manreet K. Kanwar, Karen Mcrae, Antonio Roman, Ryan Tedford, Roberto Badagliacca, Sonja Bartolome, Raymond Benza, Marco Caccamo, Rebecca Cogswell, Celine Dewachter, Laura Donahoe, Elie Fadel, Harrison W. Farber, Jeffrey Feinstein, Veronica Franco, Robert Frantz, Michael Gatzoulis, Choon Hwa (Anne) Goh, Marco Guazzi, Georg Hansmann, Stuart Hastings, Paul M. Heerdt, Anna Hemnes, Antoine Herpain, Chih-Hsin Hsu, Kim Kerr, Nicholas A. Kolaitis, Jasleen Kukreja, Michael Madani, Stuart McCluskey, Michael McCulloch, Bernhard Moser, Manchula Navaratnam, Goran Radegran, Cara Reimer, Laurent Savale, Oksana A. Shlobin, Jana Svetlichnaya, Keith Swetz, Jessica Tashjian, Thenappan Thenappan, Carmine Dario Vizza, Shawn West, Warren Zuckerman, Andreas Zuckermann, Teresa De Marco

Summary: This document is the first international consensus statement on the perioperative management of patients with pulmonary hypertension and right heart failure. It provides recommendations for managing patients with pulmonary hypertension being considered for surgery, including preoperative risk assessment, planning, intra- and postoperative monitoring and management strategies that can improve outcomes.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report-2022; focus on infant heart transplantation

Tajinder P. Singh, Wida S. Cherikh, Eileen Hsich, Michael O. Harhay, Don Hayes, Michael Perch, Luciano Potena, Aparna Sadavarte, Andreas Zuckermann, Josef Stehlik

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease

Eileen Hsich, Tajinder P. Singh, Wida S. Cherikh, Michael O. Harhay, Don Hayes, Michael Perch, Luciano Potena, Aparna Sadavarte, Kelsi Lindblad, Andreas Zuckermann, Josef Stehlik

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Donor heart selection: Evidence-based guidelines for providers

Hannah Copeland, Ivan Knezevic, David A. Baran, Vivek Rao, Michael Pham, Finn Gustafsson, Sean Pinney, Brian Lima, Marco Masetti, Agnieszka Ciarka, Navin Rajagopalan, Adriana Torres, Eileen Hsich, Jignesh K. Patel, Livia Adams Goldraich, Monica Colvin, Javier Segovia, Heather Ross, Mahazarin Ginwalla, Babak Sharif-Kashani, MaryJane A. Farr, Luciano Potena, Jon Kobashigawa, Maria G. Crespo-Leiro, Natasha Altman, Florian Wagner, Jennifer Cook, Valentina Stosor, Paolo A. Grossi, Kiran Khush, Tahir Yagdi, Susan Restaino, Steven Tsui, Daniel Absi, George Sokos, Andreas Zuckermann, Brian Wayda, Joost Felius, Shelley A. Hall

Summary: The proposed guidelines for donor heart selection are evidence-based and expert-consensus recommendations that were compiled by an international panel of experts after an extensive literature review.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Immunology

Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies

Katelynn S. Madill-Thomsen, Jeff Reeve, Arezu Aliabadi-Zuckermann, Martin Cadeiras, Marisa G. Crespo-Leiro, Eugene C. Depasquale, Mario Deng, Johannes Goekler, Daniel H. Kim, Jon Kobashigawa, Peter Macdonald, Luciano Potena, Keyur Shah, Josef Stehlik, Andreas Zuckermann, Philip F. Halloran

Summary: Using genome-wide microarray measurements, a molecular classification of parenchymal injury in heart transplants was developed. T cell-mediated rejection and antibody-mediated rejection have differential impacts on the parenchyma, with the latter contributing significantly to late dysfunction. This classification provides new insights into dysfunction and outcomes in heart transplants.

TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

Christoph Sinning, Elvin Zengin, Gerhard-Paul Diller, Francesco Onorati, Maria-Angeles Castel, Thibault Petit, Yih-Sharng Chen, Mauro Lo Rito, Carmelina Chiarello, Romain Guillemain, Karine Nubret-Le Coniat, Christina Magnussen, Dorit Knappe, Peter Moritz Becher, Benedikt Schrage, Jacqueline M. Smits, Andreas Metzner, Christoph Knosalla, Felix Schoenrath, Oliver Miera, Mi-Young Cho, Alexander Bernhardt, Jessica Weimann, Alina Gossling, Amedeo Terzi, Antonio Amodeo, Sara Alfieri, Emanuela Angeli, Luca Ragni, Carlo Pace Napoleone, Gino Gerosa, Nicola Pradegan, Inez Rodrigus, Julia Dumfarth, Michel de Pauw, Katrien Francois, Olivier Van Caenegem, Arnaut Ancion, Johan Van Cleemput, Davor Milicic, Ajay Moza, Peter Schenker, Josef Thul, Michael Steinmetz, Gregor Warnecke, Fabio Ius, Susanne Freyt, Murat Avsar, Tim Sandhaus, Assad Haneya, Sandra Eifert, Diyar Saeed, Michael Borger, Henryk Welp, Laszlo Ablonczy, Bastian Schmack, Arjang Ruhparwar, Shiho Naito, Xiaoqin Hua, Nina Fluschnik, Moritz Nies, Laura Keil, Juliana Senftinger, Djemail Ismaili, Shinwan Kany, Dora Csengeri, Massimo Cardillo, Alessandra Oliveti, Giuseppe Faggian, Richard Dorent, Carine Jasseron, Alicia Perez Blanco, Jose Manuel Sobrino Marquez, Raquel Lopez-Vilella, Ana Garcia-Alvarez, Maria Luz Polo Lopez, Alvaro Gonzalez Rocafort, Oscar Gonzalez Fernandez, Raquel Prieto-Arevalo, Eduardo Zatarain-Nicolas, Katrien Blanchart, Aude Boignard, Pascal Battistella, Soulef Guendouz, Lucile Houyel, Marylou Para, Erwan Flecher, Arnaud Gay, Eric Epailly, Camille Dambrin, Kaitlyn Lam, Cally Ho Ka-lai, Yang Hyun Cho, Jin-Oh Choi, Jae-Joong Kim, Louise Coats, David Steven Crossland, Lisa Mumford, Samer Hakmi, Cumaraswamy Sivathasan, Larissa Fabritz, Stephan Schubert, Jan Gummert, Michael Huebler, Peter Jacksch, Andreas Zuckermann, Gunther Laufer, Helmut Baumgartner, Alessandro Giamberti, Hermann Reichenspurner, Paulus Kirchhof

Summary: The ARTORIA-R study plans to collect retrospective data from 1989-2020 and include prospective patients to provide robust information on current management and outcomes of adults with congenital heart disease suffering from advanced heart failure.

ESC HEART FAILURE (2022)

No Data Available